Keywords: gpc, biotech, begins, ph, ii, satraplatin, study

GPC Biotech begins Ph II satraplatin study in NSCLC

Article | 07 August 2006

Print This

German biopharmaceutical firm GPC Biotech AG says that it has begun a Phase II trial of satraplatin, in combination with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in